Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DocCheck AGFRA:AJ91 +0.87%71 Median PS Value is €15.26 as of Jul. 22, 2026, which is 100% below its 10-year median of 0.79. GuruFocus rates FRA:AJ91 with a GF Score™ of 71/100 and a GF Value™ of €9.28 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 261 Healthcare Providers & Services companies, DocCheck AG ranks worse than 52.87% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. DocCheck AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €10.902. DocCheck AG's 10-Year median PS Ratio is 1.3997. Therefore, the Median PS Value for today is €15.26.
As of today (2026-07-22), DocCheck AG's share price is €11.60. DocCheck AG's Median PS Value is €15.26. Therefore, DocCheck AG's Price to Median PS Value for today is 0.76.
The historical rank and industry rank for DocCheck AG's Median PS Value or its related term are showing as below:
FRA:AJ91'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.51 Med: 0.79 Max: 1.19
Current: 0.76
During the past 13 years, the highest Price to Median PS Value of DocCheck AG was 1.19. The lowest was 0.51. And the median was 0.79.
FRA:AJ91's Price-to-Median-PS-Value is ranked worse than 52.87% of 261
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs FRA:AJ91: 0.76
DocCheck AG (FRA:AJ91) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
DocCheck AG's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
11.60
/
15.26
=
0.76
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG Median PS Value Related Terms
DocCheck AG Median PS Value Historical Data
* Premium members only.
The historical data trend for DocCheck AG's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AJ91 vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, DocCheck AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocCheck AG Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocCheck AG's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where DocCheck AG's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.3997.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DocCheck AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €10.902.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocCheck AG (FRA:AJ91) has a Median PS Value of €15.26 as of Jul. 22, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on DocCheck AG and its competitors. This is 1832% above median its historical median of 0.79. Over the past decade, DocCheck AG's Median PS Value has ranged from 0.51 to 1.19. According to the industry distribution chart, DocCheck AG ranks #138 out of 261 companies in the Healthcare Providers & Services industry, placing it in the top 52.9%.
Is DocCheck AG's Median PS Value too high?
DocCheck AG's current Median PS Value of €15.26 is 1832% above median its 10-year median of 0.79. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 1.19. Based on the distribution chart, DocCheck AG ranks #138 out of 261 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DocCheck AG has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DocCheck AG's Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DocCheck AG ranks #138 out of 261 companies for Median PS Value. This places DocCheck AG in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, DocCheck AG's own Median PS Value has ranged from 0.51 to 1.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 261 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on DocCheck AG and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DocCheck AG's current Median PS Value is €15.26, which is 1832% above median its own 10-year median of 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocCheck AG stock overvalued right now?
Based on GuruFocus' analysis, DocCheck AG (FRA:AJ91) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.28, compared to a current price of €11.60 — trading 25% above its estimated fair value. The current Median PS Value is €15.26, which is 1832% above median its 10-year median of 0.79. DocCheck AG's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For DocCheck AG (FRA:AJ91), the current Median PS Value is €15.26 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocCheck AG (FRA:AJ91) Overvalued in 2026?
Based on GuruFocus' analysis, DocCheck AG stock appears to be overvalued.
The current stock price of €11.60 is trading 25% above its estimated GF Value™ of €9.28.
GuruFocus considers DocCheck AG to be Modestly Overvalued.
Key valuation signals for FRA:AJ91:
Median PS Value: €15.26 (1832% above median its 10-year median of 0.79)
GF Value™: €9.28 vs. price of €11.60 (25% above fair value)
No single metric tells the full story. See the FRA:AJ91 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
71GF Score
Get the complete analysis for FRA:AJ91
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AJ91 has been successfully added to your 
